Clinical Trial Comparing TaurolockTMHep100 (Taurolidine 1.35%) and 0.9% Saline As Prevention of Recurrent Catheter-related Bloodstream Infections

NCT06660641 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Catheter Related Blood Stream Infections
Intestinal Failure

Interventions

DEVICE: TaurolockTMHep100
DEVICE: 0.9 % saline

Sponsor

Rigshospitalet, Denmark

Collaborators

[object Object]